FR2421176A1 - Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments - Google Patents

Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments

Info

Publication number
FR2421176A1
FR2421176A1 FR7809126A FR7809126A FR2421176A1 FR 2421176 A1 FR2421176 A1 FR 2421176A1 FR 7809126 A FR7809126 A FR 7809126A FR 7809126 A FR7809126 A FR 7809126A FR 2421176 A1 FR2421176 A1 FR 2421176A1
Authority
FR
France
Prior art keywords
antihypertensives
useful
alkyl
ergolenyl
hydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7809126A
Other languages
English (en)
Other versions
FR2421176B1 (fr
Inventor
Peter Gull
Theodor Fehr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to FR7809126A priority Critical patent/FR2421176A1/fr
Publication of FR2421176A1 publication Critical patent/FR2421176A1/fr
Application granted granted Critical
Publication of FR2421176B1 publication Critical patent/FR2421176B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

L'invention concerne de nouveaux dérivés de l'ergot de seigle et leur préparation. Les composés de l'invention répondent à la formule :
FR7809126A 1978-03-29 1978-03-29 Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments Granted FR2421176A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7809126A FR2421176A1 (fr) 1978-03-29 1978-03-29 Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7809126A FR2421176A1 (fr) 1978-03-29 1978-03-29 Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
FR2421176A1 true FR2421176A1 (fr) 1979-10-26
FR2421176B1 FR2421176B1 (fr) 1980-10-10

Family

ID=9206389

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7809126A Granted FR2421176A1 (fr) 1978-03-29 1978-03-29 Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments

Country Status (1)

Country Link
FR (1) FR2421176A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2500454A1 (fr) * 1981-02-24 1982-08-27 Sandoz Sa Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
FR2528432A1 (fr) * 1982-06-14 1983-12-16 Sandoz Sa Nouveaux derives de l'ergoline
EP0159522A1 (fr) * 1984-03-16 1985-10-30 Schering Aktiengesellschaft 3-(6-Méthylergolin-8 alpha-yl)-1.1-diéthyl-urée comme antihypertensif
US4713457A (en) * 1985-02-21 1987-12-15 Maruko Seiyaku Co., Ltd. Ergoline derivatives and acid addition salts thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557118A (en) * 1966-07-29 1971-01-19 Federico Arcamone 1,6-dimethyl-2,3-dihydro-10alpha-ergoline derivatives
FR2297628A1 (fr) * 1975-01-20 1976-08-13 Lilly Co Eli 2,3-dihydroergolines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3557118A (en) * 1966-07-29 1971-01-19 Federico Arcamone 1,6-dimethyl-2,3-dihydro-10alpha-ergoline derivatives
FR2297628A1 (fr) * 1975-01-20 1976-08-13 Lilly Co Eli 2,3-dihydroergolines

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2500454A1 (fr) * 1981-02-24 1982-08-27 Sandoz Sa Nouveaux derives de l'ergoline, leur preparation et leur application comme medicaments
FR2528432A1 (fr) * 1982-06-14 1983-12-16 Sandoz Sa Nouveaux derives de l'ergoline
EP0159522A1 (fr) * 1984-03-16 1985-10-30 Schering Aktiengesellschaft 3-(6-Méthylergolin-8 alpha-yl)-1.1-diéthyl-urée comme antihypertensif
US4713457A (en) * 1985-02-21 1987-12-15 Maruko Seiyaku Co., Ltd. Ergoline derivatives and acid addition salts thereof

Also Published As

Publication number Publication date
FR2421176B1 (fr) 1980-10-10

Similar Documents

Publication Publication Date Title
MY108261A (en) Water soluble camptothecin derivatives
MY101207A (en) Treatment of diseases caused by retroviruses
MY129973A (en) Sulphonylbenzyl-substituted pyridones.
IE41374L (en) Composition for treating schizophrenia
KR910019618A (ko) 발기부전증 치료용 제약 조성물
EP0105361A4 (fr) Antagonisme de medicaments du systeme nerveux par administration de 4-aminopyridine seule ou en combinaison avec d'autres medicaments.
DK0615754T3 (da) Faste flupertinholdige orale administrationsformer med kontrolleret frigivelse af den aktive forbindelse
FR2421176A1 (fr) Nouveaux derives de l'ergot de seigle, leur preparation et leur application comme medicaments
ATE152352T1 (de) Pharmazeutische zusammensetzungen zur hemmung der maillardreaktion
BR9713653B1 (pt) composiÇço farmacÊutica, mÉtodo para preparar uma composiÇço farmacÊutica, e, uso de pirofosfato fÉrrico.
ES2043744T3 (es) Sistema de suministro transdermico de procaterol.
DK0618798T3 (da) Pyridylguanidinforbindelser til behandling af erektiv dysfunktion.
ATE66620T1 (de) Dialysevorrichtung.
DE3871251D1 (de) Topische oelzusammensetzungen mit erhoehter zaehigkeit und verfahren zu deren herstellung.
EP0446921A3 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
IE33382L (en) Hexahydroazepines
FR2667243B1 (fr) Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
EP0080940A3 (en) Derivatives of 2-phenyl-morpholine and their uses as medicines
EG18031A (en) Dihydropyridiniellactols,process for their preparation and their use as medicaments
NZ333587A (en) Topiramate derivatives useful in treating psoriasis
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
DE69503229D1 (de) Verfahren zur herstellung von (1h-tetrazol-5-yl)tetrazolo[1,5-a]quinolinen und naphthridinen
RO102780B1 (ro) Metoda de anestezie generala
NL6908529A (en) Benzomorphanes as analgesics and morphine- - autogenists
IT1209298B (it) Composizione farmaceutica per la somministrazione topica di nifedipina.

Legal Events

Date Code Title Description
ST Notification of lapse